S&P 500   3,379.16 (+1.31%)
DOW   27,923.76 (+1.72%)
QQQ   279.71 (+1.36%)
AAPL   116.21 (+1.86%)
MSFT   210.93 (+1.77%)
FB   263.03 (+0.47%)
GOOGL   1,476.07 (+0.69%)
AMZN   3,192.67 (+1.52%)
TSLA   427.84 (+2.09%)
NVDA   540.50 (+2.17%)
BABA   291.15 (+5.13%)
CGC   14.49 (-0.07%)
GE   6.27 (+2.45%)
MU   47.72 (-5.90%)
AMD   81.87 (+0.12%)
T   28.58 (+0.99%)
F   6.68 (+1.21%)
ACB   4.71 (+0.64%)
GILD   62.87 (+1.24%)
NFLX   499.98 (+1.32%)
DIS   124.86 (-0.43%)
BA   168.69 (+3.11%)
BAC   24.21 (+1.85%)
S&P 500   3,379.16 (+1.31%)
DOW   27,923.76 (+1.72%)
QQQ   279.71 (+1.36%)
AAPL   116.21 (+1.86%)
MSFT   210.93 (+1.77%)
FB   263.03 (+0.47%)
GOOGL   1,476.07 (+0.69%)
AMZN   3,192.67 (+1.52%)
TSLA   427.84 (+2.09%)
NVDA   540.50 (+2.17%)
BABA   291.15 (+5.13%)
CGC   14.49 (-0.07%)
GE   6.27 (+2.45%)
MU   47.72 (-5.90%)
AMD   81.87 (+0.12%)
T   28.58 (+0.99%)
F   6.68 (+1.21%)
ACB   4.71 (+0.64%)
GILD   62.87 (+1.24%)
NFLX   499.98 (+1.32%)
DIS   124.86 (-0.43%)
BA   168.69 (+3.11%)
BAC   24.21 (+1.85%)
S&P 500   3,379.16 (+1.31%)
DOW   27,923.76 (+1.72%)
QQQ   279.71 (+1.36%)
AAPL   116.21 (+1.86%)
MSFT   210.93 (+1.77%)
FB   263.03 (+0.47%)
GOOGL   1,476.07 (+0.69%)
AMZN   3,192.67 (+1.52%)
TSLA   427.84 (+2.09%)
NVDA   540.50 (+2.17%)
BABA   291.15 (+5.13%)
CGC   14.49 (-0.07%)
GE   6.27 (+2.45%)
MU   47.72 (-5.90%)
AMD   81.87 (+0.12%)
T   28.58 (+0.99%)
F   6.68 (+1.21%)
ACB   4.71 (+0.64%)
GILD   62.87 (+1.24%)
NFLX   499.98 (+1.32%)
DIS   124.86 (-0.43%)
BA   168.69 (+3.11%)
BAC   24.21 (+1.85%)
S&P 500   3,379.16 (+1.31%)
DOW   27,923.76 (+1.72%)
QQQ   279.71 (+1.36%)
AAPL   116.21 (+1.86%)
MSFT   210.93 (+1.77%)
FB   263.03 (+0.47%)
GOOGL   1,476.07 (+0.69%)
AMZN   3,192.67 (+1.52%)
TSLA   427.84 (+2.09%)
NVDA   540.50 (+2.17%)
BABA   291.15 (+5.13%)
CGC   14.49 (-0.07%)
GE   6.27 (+2.45%)
MU   47.72 (-5.90%)
AMD   81.87 (+0.12%)
T   28.58 (+0.99%)
F   6.68 (+1.21%)
ACB   4.71 (+0.64%)
GILD   62.87 (+1.24%)
NFLX   499.98 (+1.32%)
DIS   124.86 (-0.43%)
BA   168.69 (+3.11%)
BAC   24.21 (+1.85%)
Log in
NYSE:NGVT

Ingevity Stock Forecast, Price & News

$50.56
+1.04 (+2.10 %)
(As of 09/30/2020 12:38 PM ET)
Add
Compare
Today's Range
$49.90
Now: $50.56
$50.79
50-Day Range
$48.21
MA: $56.80
$63.11
52-Week Range
$24.92
Now: $50.56
$94.67
Volume3,622 shs
Average Volume459,521 shs
Market Capitalization$2.09 billion
P/E Ratio12.55
Dividend YieldN/A
Beta2.28
Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the Kraft pulping process and caprolactone. This segment's products are used in various applications comprising pavement preservation, pavement adhesion promotion and warm mix paving, oil well service additives, oil production and downstream application chemicals, printing inks, adhesives, agrochemicals, lubricants and industrial intermediates, coatings resins, elastomers, adhesives, and bio-plastics. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina.
Read More
Ingevity logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.89 out of 5 stars


Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
Previous SymbolNASDAQ:NGVT
CUSIPN/A
Phone843-740-2300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.29 billion
Cash Flow$6.20 per share
Book Value$12.69 per share

Profitability

Net Income$183.70 million

Miscellaneous

Employees1,850
Market Cap$2.09 billion
Next Earnings Date10/28/2020 (Estimated)
OptionableOptionable
$50.56
+1.04 (+2.10 %)
(As of 09/30/2020 12:38 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NGVT News and Ratings via Email

Sign-up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Ingevity (NYSE:NGVT) Frequently Asked Questions

How has Ingevity's stock price been impacted by Coronavirus (COVID-19)?

Ingevity's stock was trading at $38.80 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NGVT stock has increased by 30.3% and is now trading at $50.56.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Ingevity?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Ingevity
.

When is Ingevity's next earnings date?

Ingevity is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Ingevity
.

How were Ingevity's earnings last quarter?

Ingevity Corp (NYSE:NGVT) released its earnings results on Wednesday, July, 29th. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.60 by $0.03. The business earned $270.60 million during the quarter, compared to analyst estimates of $256.30 million. Ingevity had a return on equity of 36.42% and a net margin of 13.89%. The firm's quarterly revenue was down 23.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.36 earnings per share.
View Ingevity's earnings history
.

What guidance has Ingevity issued on next quarter's earnings?

Ingevity issued an update on its FY 2020 After-Hours earnings guidance on Wednesday, July, 29th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.1-1.2 billion, compared to the consensus revenue estimate of $1.14 billion.

What price target have analysts set for NGVT?

7 brokerages have issued 1 year price objectives for Ingevity's stock. Their forecasts range from $55.00 to $94.00. On average, they expect Ingevity's stock price to reach $71.00 in the next twelve months. This suggests a possible upside of 40.4% from the stock's current price.
View analysts' price targets for Ingevity
.

Who are some of Ingevity's key competitors?

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Verizon Communications (VZ), Westrock (WRK), Abbott Laboratories (ABT), Boeing (BA), Costco Wholesale (COST), Dominion Energy (D) and Johnson & Johnson (JNJ).

Who are Ingevity's key executives?

Ingevity's management team includes the following people:
  • Mr. D. Michael Wilson, Pres, CEO & Director (Age 56)
  • Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 52)
  • Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 61)
  • Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 53)
  • Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 58)

What is Ingevity's stock symbol?

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

How do I buy shares of Ingevity?

Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ingevity's stock price today?

One share of NGVT stock can currently be purchased for approximately $50.56.

How big of a company is Ingevity?

Ingevity has a market capitalization of $2.09 billion and generates $1.29 billion in revenue each year. The company earns $183.70 million in net income (profit) each year or $4.93 on an earnings per share basis. Ingevity employs 1,850 workers across the globe.

What is Ingevity's official website?

The official website for Ingevity is www.ingevity.com.

How can I contact Ingevity?

Ingevity's mailing address is 4920 O`Hear Avenue Suite 400, North Charleston SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]

This page was last updated on 9/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.